CNS Strangle Strategy
CNS (Cohen & Steers, Inc.), in the Financial Services sector, (Asset Management industry), listed on NYSE.
Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities. Additionally, these subsidiaries develop and oversee a diverse range of investment vehicles, including mutual funds (focused on equity, fixed income, balanced, and multi-asset classes) and hedge funds. The company's global investment strategy, implemented via its affiliated entities, involves allocating capital in public equity, fixed income, and commodity markets. For its equity and fixed income allocations, the firm's affiliates specifically target businesses within the real estate industry (including REITs), infrastructure, and natural energy resources.
CNS (Cohen & Steers, Inc.) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $4.03B, a trailing P/E of 25.88, a beta of 1.23 versus the broader market, a 52-week range of 58.39-78.81, average daily share volume of 304K, a public-listing history dating back to 2004, approximately 411 full-time employees. These structural characteristics shape how CNS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.23 places CNS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. CNS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on CNS?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current CNS snapshot
As of June 29, 2026, spot at $75.13, ATM IV 132.40%, IV rank 25.59%, expected move 37.96%. The strangle on CNS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this strangle structure on CNS specifically: CNS IV at 132.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a CNS strangle, with a market-implied 1-standard-deviation move of approximately 37.96% (roughly $28.52 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CNS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CNS should anchor to the underlying notional of $75.13 per share and to the trader's directional view on CNS stock.
CNS strangle setup
The CNS strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CNS near $75.13, the first option leg uses a $78.89 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CNS chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CNS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $78.89 | N/A |
| Buy 1 | Put | $71.37 | N/A |
CNS strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
CNS strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on CNS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on CNS
Strangles on CNS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CNS chain.
CNS thesis for this strangle
The market-implied 1-standard-deviation range for CNS extends from approximately $46.61 on the downside to $103.65 on the upside. A CNS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CNS IV rank near 25.59% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CNS at 132.40%. As a Financial Services name, CNS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CNS-specific events.
CNS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CNS positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CNS alongside the broader basket even when CNS-specific fundamentals are unchanged. Always rebuild the position from current CNS chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on CNS?
- A strangle on CNS is the strangle strategy applied to CNS (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CNS stock trading near $75.13, the strikes shown on this page are snapped to the nearest listed CNS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CNS strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CNS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 132.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CNS strangle?
- The breakeven for the CNS strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CNS market-implied 1-standard-deviation expected move is approximately 37.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on CNS?
- Strangles on CNS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CNS chain.
- How does current CNS implied volatility affect this strangle?
- CNS ATM IV is at 132.40% with IV rank near 25.59%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.